Interestingly, our results demonstrate that nuclear pERK expression parallels tumor grade and tumor stage (Table 2, Figure 2) in keeping with findings of previous studies in NSCLC and prostate cancer [30,34]. The gene discussed is EIF2AK3; the disease is Familial prostate cancer.